1. It is NOT WRONG to label Merck’s shareholders and the FDA as salient. You should still make sure to address the other stakeholders and why you did not choose them to be salient.

2. I talked with Firat about this after class a bit, but I just don’t see your argument about promoting to doctors and DTC as main problems. Convince me that these problems affect your salient stakeholders the most, and then I’ll believe it. If you choose these problems, your salient stakeholders should be doctors and consumers, not shareholders and the FDA.

3. I have given you LOTS of advice on how to make both better, so why don’t you work on those first.

4. At this stage, the paper would probably get a C.

5. You should follow all the advice I gave you in several emails and on the paper itself! Look at my “how to write effectively and concisely” handout and make sure you go to a writing tutor.